The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial.
 
Amrita B Basu
Travel, Accommodations, Expenses - Leidos Health
 
Saumya Umashankar
No Relationships to Disclose
 
Mina Musthafa
No Relationships to Disclose
 
Tamia Jones
No Relationships to Disclose
 
Kaylee Blevins
No Relationships to Disclose
 
Thelma Brown
No Relationships to Disclose
 
Diane Heditsian
Stock and Other Ownership Interests - Johnson & Johnson
 
Beverly Parker
No Relationships to Disclose
 
Susie Brain
No Relationships to Disclose
 
Carol Simmons
No Relationships to Disclose
 
Tina J. Hieken
Research Funding - Genentech/Roche (Inst); Skyline Diagnostics (Inst)
 
Kathryn Jean Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Candace Bavette Mainor
Research Funding - cantex (Inst); Pfizer (Inst)
 
Sarah Emily Amend Tevis
No Relationships to Disclose
 
Anne Hudson Blaes
Research Funding - Dompé Farmaceutici
 
Hope S. Rugo
Consulting or Advisory Role - Daiichi Sankyo; Eisai; Mylan; Napo Pharmaceuticals; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hoffmann-La Roche AG/Genentech, Inc (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Pionyr (Inst); Sermonix Pharmaceuticals (Inst); Taiho Oncology (Inst); Veru (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Merck
 
Imogene Dunn
Employment - Quantum Leap Healthcare Collaborative
 
Michelle E. Melisko
Stock and Other Ownership Interests - Merrimack (I)
Speakers' Bureau - AstraZeneca (I); Genentech (I); Gilead Sciences (I)
Research Funding - DAEHWA Pharmaceutical (Inst); Novartis (Inst); OBI Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Multiple patents related to immunoliposomal drugs being studied and potentially brought to market by Merrimack (I)
Expert Testimony - GlaxoSmithKline
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health